Ruchir Sehra, M.D., is a health and software entrepreneur and inventor with over 100 worldwide patents issued. Dr. Sehra has extensive experience leading companies from idea through exit, driving company mission, product and team development, financing, venture investing, and exit strategies. Dr. Sehra currently serves as the CEO and President of Resonea, Inc, which was founded in 2016. Resonea’s mission is to develop a new standard for understanding sleep breathing and its impact on the human condition. Dr. Sehra was previously the Chief Medical Officer of Abbott Electrophysiology, joining Abbott through the acquisition of Topera, Inc., a company which he co-founded. Topera was a venture backed medical device company that developed a novel 3-D analysis and mapping system to assist electrophysiologists in the identification of the electrical source of complex cardiac arrhythmias.